N
EOLS icon

Natixis’s Evolus EOLS Stock Holding History

Natixis’s Portfolio EOLS Stock Details EOLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$581K Buy
141,437
+140,000
+9,743% +$678K ﹤0.01% 786
2025
Q4 		$9.56K Sell
1,437
-1,588
-52% -$10.8K ﹤0.01% 1051
2025
Q3 		$18.6K Sell
3,025
-227
-7% -$1.77K ﹤0.01% 970
2025
Q2 		$30K Sell
3,252
-1,247
-28% -$12.8K ﹤0.01% 910
2025
Q1 		$53.2K Hold
4,499
– – ﹤0.01% 826
2024
Q4 		$49.7K Sell
4,499
-794
-15% -$11.2K ﹤0.01% 883
2024
Q3 		$85.7K Sell
5,293
-982
-16% -$13.7K ﹤0.01% 758
2024
Q2 		$68.1K Sell
6,275
-28,671
-82% -$353K ﹤0.01% 767
2024
Q1 		$489K Buy
+34,946
New +$454K ﹤0.01% 640

Other funds holding EOLS

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Natixis's EOLS Position: Q1 2026 in Review

Natixis increased its Evolus (EOLS) stake by 9,743% in Q1 2026, buying an estimated $678K and bringing the position to 141,437 shares worth $581K. The position accounts for ﹤0.01% of the portfolio, ranked #786.

Natixis first reported a position in EOLS in Q1 2024 and has held it in 9 quarters since. 147 funds tracked by Wall St. Rank hold EOLS as of Q1 2026.

  • Natixis held 141,437 shares of Evolus worth $581K as of Q1 2026.
  • Natixis bought 140,000 Evolus shares in Q1 2026, an estimated $678K.
  • Evolus made up ﹤0.01% of Natixis's portfolio in Q1 2026, its #786 holding.
  • Natixis first reported a position in Evolus in Q1 2024 and has held it in 9 quarters since.
  • 147 funds tracked by Wall St. Rank held Evolus as of Q1 2026.

Based on Natixis's 13F filing for Q1 2026, filed 14 May 2026.